Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection

Exclusion Criteria

• •Subject who has used a topical antibacterial medication to the area being treated within the last 48 hours.
• •Subject who has been enrolled in a clinical trial within the last 30 days.
• •Subject with signs of systemic infection (such as fever), or with evidence of abscess or cellulitis at the site to be treated.
• •Subject has a bacterial skin infection which would not be appropriately treated by a topical antibiotic in the opinion of the investigator
• •Subjects who have taken oral antibiotics within the last 7 days.
• •Subjects with known sensitivity to the study medication.
• •The subject is pregnant or breastfeeding